Press Releases Archives - Page 17 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Lupin Q3 FY2024 Results

February 7, 2024

Lupin Receives Approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.075%

February 6, 2024

Lupin Launches Cyanocobalamin Nasal Spray in the United States

February 2, 2024

Lupin Receives Approval from U.S. FDA for Dronedarone Tablets, USP

February 1, 2024

Lupin Digital Health introduces Digital Therapeutics Certificate for Cardiologists in India in collaboration with the American College of Cardiology

January 30, 2024

Lupin Receives Tentative Approval from U.S. FDA for Rivaroxaban Tablets USP

January 23, 2024

Lupin Receives Approval from U.S. FDA for Febuxostat Tablets

January 18, 2024

Lupin Hosts Second Edition of Aptivate Champion Run for Kids

January 14, 2024

Lupin Receives Approval from U.S. FDA for Propranolol Hydrochloride Extended-Release Capsules USP

January 14, 2024

Lupin Launches Varenicline Tablets in the United States

January 10, 2024

1 2 … 16 17 18 … 102 103

Search

Hit enter to search or ESC to close